BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3277587)

  • 1. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
    Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
    Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.
    Norrby SR; Eriksson M; Ottosson E
    Scand J Infect Dis; 1986; 18(4):371-4. PubMed ID: 3094139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
    Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; AntĂșnez de Mayolo E
    Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections.
    Danziger LH; Creger RJ; Shwed JA; Stellato TA; Hau T
    Pharmacotherapy; 1988; 8(6):315-8. PubMed ID: 3222164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem/cilastatin versus gentamicin/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group.
    Lancet; 1984 Apr; 1(8382):868-71. PubMed ID: 6143185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
    Solomkin JS; Fant WK; Rivera JO; Alexander JW
    Am J Med; 1985 Jun; 78(6A):85-91. PubMed ID: 3890538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.
    Christen D; Buchmann P; Geroulanos S
    Scand J Infect Dis Suppl; 1987; 52():11-4. PubMed ID: 3331039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem: a new carbapenem antibiotic.
    Lipman B; Neu HC
    Med Clin North Am; 1988 May; 72(3):567-79. PubMed ID: 3280907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
    J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections.
    Larsen JW; Gabel-Hughes K; Kreter B
    Clin Ther; 1992; 14(1):90-6. PubMed ID: 1576631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin.
    Leaper DJ; Kennedy RH; Sutton A; Johnson E; Roberts N
    Scand J Infect Dis Suppl; 1987; 52():7-10. PubMed ID: 3331045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem-cilastatin: the first thienamycin antibiotic.
    Jacobs RF
    Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of imipenem/cilastatin in the empirical treatment of septicemia.
    Del Valle J; Noriega AR; Sanz F; Revilla AP; Otero JR
    Scand J Infect Dis Suppl; 1987; 52():20-5. PubMed ID: 3331040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
    Mortimer J; Miller S; Black D; Kwok K; Kirby WM
    Am J Med; 1988 Jul; 85(1A):17-20. PubMed ID: 3400679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.